Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA

ConditionsPeriarticular Block Osteoarthritis (OA)Osteoarthritis (OA) of the Knee Pain After Surgery Knee Arthroplasty, Total

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-89

SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

Prospective Cohort of patients who are scheduled for a Robot Assisted Total Knee Arthroplasty (RATKA). A prospective survey of patient reported outcome measures (Numeric Rating Scale) will be obtained postoperatively of 72 hours, as well as at the postoperative opioid consumption after 72 hours.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

bupivacaine-meloxicam (extended release)
Bupivacaine
Ketorolac
Lidocaine (drug)

Treatment groups

150 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Lead sponsor

Source ClinicalTrials.gov